Does Molina Healthcare Stock’s Run Make Any Sense?

MOHYTD+34.3%SPYYTD+9.4%XLVYTD+22.9%
Analyze MOH →

Today’s big story: Could Nvidia Stock Fall 50%? Follow The Cash

Molina Healthcare (MOH) stock returned 68.3% over the past year, against 11.4% for the S&P 500. The company lost $48 million in its last four reported quarters, making the run hard to judge: a buyer today is paying for a recovery management has laid out for 2027, not one already in the results. So how does Molina make money, and why is so little left?

Image from Pixabay

How Does Molina Healthcare Make Its Money?

Molina collects premiums to run health plans in Medicaid, Medicare and the Marketplace, paying most of that money back out for its members’ medical care. This payout share is its medical cost ratio, which was 92.9% in fiscal Q3 2026, management said on the October 22 call. That leaves only a few cents of each premium dollar to run the business and earn a profit.

In Medicaid, states set the rates Molina is paid, and in 2026 those rates are not keeping up with costs. Management expects its rates to rise 4.5% in 2026 while the cost of its members’ care rises 5.5%. At margins this thin, that gap matters: management said every percentage point of its Medicaid medical cost ratio is worth about $5 per share of earnings. That is close to its forecast of at least $5.25 per share of adjusted earnings for all of 2026.

Molina Healthcare Keeps Under A Penny Per Sales Dollar

Molina recorded an operating margin of 0.6% over the twelve months to September 30, 2026, against 18.9% for the S&P 500. Its operating margin was 3.0% a year earlier. The business now earns well under a penny of operating profit on each dollar it takes in.

The business is also getting smaller. Revenue fell below year-earlier levels in each of the last three quarters, dropping 3.4% in fiscal Q3 2026. Management said Medicaid membership was down about 4.5% so far in 2026.

What Is Molina Healthcare Stock Priced For?

Because Molina lost money over the past twelve months, its price-to-earnings ratio is not meaningful. On sales, the stock trades at 0.27 times, against 3.2 times for the S&P 500. That low figure comes from the thin margin, and a wider margin is the change that matters for it.

Management detailed that change on the October 22 call. The company said its early building blocks for 2027 add up to more than $9.50 per share of adjusted earnings from items it already knows, without counting any improvement in its older Medicaid business. It also expects 2027 Medicaid rates to at least keep pace with medical cost growth, which would close the gap between rates and costs that management called temporary. Management said it is likely seeing the beginning of the turn in Medicaid margins, and anyone who owns the stock after this run is counting on that turn.

What Could Delay Molina Healthcare’s Recovery?

State court reviews of its Medicaid awards in Georgia and Texas are taking longer than expected, and Molina now expects both new contracts to start later than planned. The delay pushes back $1.3 billion of premium, and management lowered its 2027 premium outlook to at least $45 billion, from $46.5 billion. Management said it remains confident both awards will be upheld, with the contracts starting later in 2027 or in 2028.

Molina is expected to report in February 2027, and management said it will issue its first 2027 guidance then. The Medicaid medical cost ratio in that outlook is the figure to watch.

A stock that runs this far ahead of its profits can quietly become a bigger part of your savings than you meant it to be. That is when an exit plan worked out ahead of time matters most.

Too Much Riding On One Stock?

If Molina Healthcare is a big part of your wealth, so are its risk and its tax bill. What’s your exit plan? Our partner advisory firm offers a free 30-minute strategy review covering a floor under losses and a lower-tax way out.

Map My Exit Options

Spot an error or want more like this? Tell us in 10 seconds.